Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis

Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making. 

CME information and select publications here.